Lurastar 40mg Tablet contains Lurasidone 40mg, an atypical antipsychotic agent primarily indicated for the treatment of schizophrenia and bipolar depression. Lurasidone exerts its therapeutic effects through antagonism of dopamine D2 and serotonin 5-HT2A receptors, contributing to the modulation of neurotransmitter activity in the central nervous system. This medication is prescribed to alleviate symptoms such as hallucinations, delusions, mood swings, and cognitive disturbances associated with psychotic disorders. Lurastar 40mg is typically administered once daily with food to enhance absorption and optimize plasma concentration. The dosage should be individualized based on clinical response and tolerability, with careful monitoring for adverse effects including extrapyramidal symptoms, metabolic changes, and potential QT interval prolongation. Contraindications include hypersensitivity to lurasidone or any tablet components, and caution is advised in patients with a history of cardiovascular disease, seizures, or hepatic impairment. Regular follow-up is essential to assess efficacy and safety, and abrupt discontinuation should be avoided to prevent withdrawal symptoms or relapse. Lurastar 40mg Tablet should be used under strict medical supervision, ensuring adherence to prescribed dosage and monitoring protocols to achieve optimal therapeutic outcomes in managing psychiatric conditions.